General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gisbert JP et al. - Thiopurine drugs (AZA/MP) are more effective than placebo for the prevention of relapse in UC, with an NNT of 5 and an absolute risk reduction of 23%.

Related Articles

Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09    Relevance Score: 70%

Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09    Relevance Score: 69%

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09    Relevance Score: 68%

Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09    Relevance Score: 68%

Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09    Relevance Score: 68%

Today in Inflammatory Bowel Dz...keeping you current

An analysis of the placebo effect in Crohn's disease over time
Alimentary Pharmacology and Therapeutics, 12/04/09

Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease
Journal of Cancer Research & Clinical Oncology, 12/04/09

Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address